QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

Clinical trial NCT06749899 · RECRUITING

Trial details

NCT number: NCT06749899
Sponsor: Sun Yat-Sen University Cancer Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer

Start date: 2025-05-04
Primary completion: 2028-12-01
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.